Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.

Source:http://linkedlifedata.com/resource/pubmed/id/19276281

Clin. Cancer Res. 2009 Mar 15 15 6 2098-106

Download in:

View as

General Info

PMID
19276281